# Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy

> **NCT00132873** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 59 (actual)

## Conditions studied

- Narcolepsy

## Interventions

- **DRUG:** Xyrem (sodium oxybate) oral solution

## Key facts

- **NCT ID:** NCT00132873
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-09
- **Final completion:** 2007-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132873, "Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00132873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*